CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
Kun Hae Kim, Jae Hui Kim, Young Suk Chang, Tae Gon Lee, Jong Woo Kim, Young Ju Lew
Korean J Ophthalmol. 2015;29(5):315-324.   Published online September 22, 2015
DOI: https://doi.org/10.3341/kjo.2015.29.5.315

Excel Download

Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
Korean Journal of Ophthalmology. 2015;29(5):315   Crossref logo
Link1 Link2 Link3

Long-Term Outcome of Anti-Vascular Endothelial Growth Factor Therapy Following Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration
. 2021;   Crossref logo
Link1 Link2

Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration
Eye. 2015;29(9):1141-1151   Crossref logo
Link1 Link2 Link3

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration
Ophthalmology. 2003;110(5):979-986   Crossref logo
Link1 Link2

Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5 year outcomes and implication for clinical practice
Clinical & Experimental Ophthalmology. 2017;45(4):333-335   Crossref logo
Link1 Link2

Subfoveal Choroidal Thickness in Eyes with Neovascular Age-Related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents
Ophthalmologica. 2018;240(4):200-207   Crossref logo
Link1 Link2

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
Clinical Ophthalmology. 2021;Volume 15:279-287   Crossref logo
Link1 Link2

Re: Nguyen et al.: Characterization of poor visual outcomes of neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents (Ophthalmology. 2019;126:735-742)
Ophthalmology. 2020;127(4):e21   Crossref logo
Link1 Link2

Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761)
Ophthalmology. 2017;124(3):e31-e32   Crossref logo
Link1 Link2

Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration
Ophthalmology. 2015;122(4):803-808   Crossref logo
Link1 Link2